XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jul. 31, 2022
Jul. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss, including amounts attributable to noncontrolling interest $ (88,110) $ (69,048)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 55,218 8,663
Amortization of intangible assets 1,176 169
Depreciation expense 1,286 0
Amortization of deferred contract acquisition costs 21,618 15,099
Gain from deconsolidation of Meltano Inc. (17,798) 0
Loss from equity method investment 1,290 0
Net amortization of premiums or discounts on short-term investments (1,293) 0
Unrealized foreign exchange (gain) loss (1,572) 9,839
Other non-cash (income) expense 469 (143)
Changes in assets and liabilities:    
Accounts receivable (13,568) (7,059)
Prepaid expenses and other current assets (5,488) (215)
Deferred contract acquisition costs (21,210) (15,112)
Other long-term assets 2,700 (1,918)
Accounts payable 528 (1,189)
Accrued expenses and other current liabilities 90 4,910
Accrued compensation and benefits (16,680) (2,385)
Deferred revenue 17,549 19,613
Other long-term liabilities (696) 135
Net cash used in operating activities (64,491) (38,641)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of short-term investments (520,664) (50,000)
Proceeds from maturities of short-term investments 50,031 0
Purchases of property and equipment (3,234) 0
Deconsolidation of Meltano Inc. (9,620) 0
Net cash used in investing activities (483,487) (50,000)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from the issuance of common stock upon exercise of stock options, including early exercises, net of repurchases 11,311 7,652
Issuance of common stock under employee stock purchase plan 9,554 0
Repurchase of common stock in a tender offer 0 (590)
Contributions received from noncontrolling interests, net of issuance costs 57,673 26,450
Payments of deferred offering costs 0 (825)
Net cash provided by financing activities 78,538 32,687
Impact of foreign exchange on cash and cash equivalents (4,475) (642)
Net decrease in cash and cash equivalents (473,915) (56,596)
Cash, cash equivalents, and restricted cash at beginning of period 887,172 282,850
Cash, cash equivalents, and restricted cash at end of period 413,257 226,254
Supplemental disclosure of cash flow information:    
Cash paid for income taxes 309 631
Cash donations 0 1,000
Supplemental disclosure of non-cash investing and financing activities:    
Vesting of early exercised stock options 2,960 1,453
Unpaid deferred offering costs 0 473
Reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets to the amounts shown in the consolidated statements of cash flows above:    
Cash and cash equivalents 410,757 [1] 226,254
Restricted cash, current included in prepaid expenses and other current assets 2,500 0
Total cash, cash equivalents and restricted cash $ 413,257 $ 226,254
[1] (1) As of July 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $60.9 million and $17.7 million, respectively, and liabilities of $3.6 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.